SCHEMBL7995201

SCHEMBL7995201

COC(=O)C(CCc1ccncc1)C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.46
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
MMP12 P39900 1/20 0.42
MMP13 P45452 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
NAMPT P43490 1/20 0.42
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.38
KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6646153 0.85 NAMPT (0.47) CYP19A1ALDH1A1SMN1; SMN2MMP12MMP13
SCHEMBL22444679 0.83 CYP19A1 (0.44) CYP19A1ALDH1A1SMN1; SMN2MMP12MMP13
Hydrochloric Acid SCHEMBL7205435 0.83 NAMPT (0.46) CYP19A1ALDH1A1SMN1; SMN2MMP12MMP13
SCHEMBL21855665 0.83 CYP3A4 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL7056381 0.82 TSHR (0.53) ALDH1A1SMN1; SMN2MMP12NPC1RAB9A
SCHEMBL21959944 0.81 MEN1 (0.42) SMN1; SMN2NPC1RAB9AMAPTNAMPT
SCHEMBL17783704 0.80 ROCK2 (0.44) CYP19A1ALDH1A1SMN1; SMN2NAMPTTSHR
SCHEMBL27496396 0.80 MMP12 (0.51) CYP19A1SMN1; SMN2MMP12MMP13RAB9A
SCHEMBL5349016 0.76 ACACB (0.54) ALDH1A1NPC1RAB9ALMNAMAPT
SCHEMBL742552 0.76 TDP1 (0.50) CYP19A1ALDH1A1LMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294549-B1 COMPOUNDS USEFUL FOR INHIBITING RESTENOSIS, ANGIOGENESIS, ATHEROSCLEROSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, INFLAMMATION OR TUMOR GROWTH. MERCK & CO., INC. 2001-09-25 US disclosed
US-5952306-A INHIBITING THE BINDING OF FIBRINOGEN TO BLOOD PLATELETS AND INHIBITING THE AGGREGATION OF BLOOD PLATELETS; INHIBITING OSTEOCLAST CELLULAR ADHESION TO BONE SURFACES MERCK & CO., INC. (US) 1999-09-14 US disclosed